ReNeuron and VistaGen Announce Broad Stem Cell Drug Discovery Alliance
(PR Newswire)ReNeuron Holdings plc, a leading British bio-pharmaceutical company focused on treatment of brain disorders, and VistaGen, Inc., a private U.S. biotechnology company developing a portfolio of in vitro stem cell technologies, announced today a broad strategic alliance to exploit the considerable commercial potential of their respective stem cell drug discovery and predictive screening platforms.- Jun 20 7:01 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010620/sfw016b.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines